Mycosis fungoides treated with a combination of topical psoralen and ultraviolet A, interferon gamma-1a, and low-dose etoposide therapy : A case report

Skin Cancer ◽  
2018 ◽  
Vol 32 (3) ◽  
pp. 256-260
Author(s):  
Akiko ADACHI ◽  
Sadao MASAKI ◽  
Masashi AKIYAMA
Keyword(s):  
Case Report ◽  
Mycosis Fungoides ◽  
Interferon Gamma ◽  
Low Dose ◽  
Ultraviolet A

Efficacy of Low-Dose Ultraviolet A-1 Phototherapy for Parapsoriasis/Early-Stage Mycosis Fungoides

2014 ◽  
pp. n/a-n/a ◽  
Author(s):  
Kenan Aydogan ◽  
Serkan Yazici ◽  
Saduman Balaban Adim ◽  
Isil Tilki Gunay ◽  
Ferah Budak ◽  
...  
Keyword(s):  
Mycosis Fungoides ◽  
Low Dose ◽  
Early Stage ◽  
Ultraviolet A

Mycosis fungoides: Case report treated with low-dose palliative radiotherapy

2013 ◽  
Vol 18 ◽  
pp. S276-S277
Author(s):  
M. Veiras Lens ◽  
M. Sanchez Belda ◽  
E. Arregui Lopez ◽  
I. Trueba Garayo ◽  
R. Poza de Celis ◽  
...  
Keyword(s):  
Case Report ◽  
Mycosis Fungoides ◽  
Low Dose ◽  
Palliative Radiotherapy

scholarly journals Ultra-Low-Dose Radiotherapy for Palliation of Mycosis Fungoides

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
İpek Pınar Aral ◽  
Neşe Göçer Gürok ◽  
Aykut Oğuz Konuk ◽  
Özlem Üçer
Keyword(s):  
Case Report ◽  
T Cell ◽  
Total Dose ◽  
Mycosis Fungoides ◽  
Outpatient Clinic ◽  
Low Dose ◽  
Systemic Treatment ◽  
Multiorgan Failure ◽  
T Cell Lymphomas ◽  
Low Dose Radiotherapy

Introduction. Mycosis fungoides (MF) is a form of primary cutaneous T-cell lymphomas, and radiotherapy (RT) has been used to treat localized/limited lesions of MF. In this case report, the results of low-dose RT applied for palliative purpose are shared. Case Report. A 70-year-old male patient was admitted to the outpatient clinic 7 months ago with a generalized itchy rash. The result of the biopsy was reported as mycosis fungoides. Systemic treatment was not performed due to comorbid diseases. The hemibody RT was applied. 2 Gy was given per fraction, with a total dose of 6 Gy. The significant clinical relief was observed with 6 Gy RT. The patient died due to multiorgan failure 2 months later, and no recurrence was observed. Conclusion. The palliation was achieved in the advanced MF patient with fractionated 6 Gy hemibody RT for the remaining 2 months of life.

scholarly journals A case report of therapeutically challenging chronic actinic dermatitis

2019 ◽  
Vol 7 ◽  
pp. 2050313X1984523 ◽  
Author(s):  
Luvneet Verma ◽  
Melanie Pratt
Keyword(s):  
Monoclonal Antibody ◽  
Atopic Dermatitis ◽  
Mycophenolate Mofetil ◽  
Case Report ◽  
Partial Response ◽  
Low Dose ◽  
Immunosuppressive Agents ◽  
Ultraviolet A ◽  
Chronic Actinic Dermatitis ◽  
Systemic Agents

Chronic actinic dermatitis is a difficult to treat photodermatitis. Treatment is not standardized and involves topical corticosteroids and immunomodulators, and systemic immunosuppressive agents. We present a case with partial response to dupilumab, a monoclonal antibody approved for atopic dermatitis. In recalcitrant cases, systemic agents such as methotrexate, azathioprine, mycophenolate mofetil, and thalidomide, extracorpeal electrophoresis, and low-dose psoralen and ultraviolet A can also be considered.

Resting Tremor during Low-dose Tricyclic Antidepressant Treatment - A case report -

2007 ◽  
Vol 20 (1) ◽  
pp. 71
Author(s):  
Young Bok Lee ◽  
Jong Taek Park ◽  
Ja Youn Jeon ◽  
Kwang Ho Lee
Keyword(s):  
Case Report ◽  
Low Dose ◽  
Antidepressant Treatment ◽  
Tricyclic Antidepressant ◽  
Resting Tremor
Sign in / Sign up

Export Citation Format

Share Document